Revolution Medicines, Inc. (RVMD)

Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $18.90 billion. The enterprise value is $17.30 billion.

Market Cap	18.90B
Enterprise Value	17.30B

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026, after market close.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

RVMD has 198.17 million shares outstanding. The number of shares has increased by 13.35% in one year.

Current Share Class	198.17M
Shares Outstanding	198.17M
Shares Change (YoY)	+13.35%
Shares Change (QoQ)	+3.93%
Owned by Insiders (%)	2.40%
Owned by Institutions (%)	93.87%
Float	178.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	336.93
PB Ratio	11.52
P/TBV Ratio	12.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.14, with a Debt / Equity ratio of 0.26.

Current Ratio	7.14
Quick Ratio	6.97
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-48.80

Financial Efficiency

Return on equity (ROE) is -58.07% and return on invested capital (ROIC) is -33.14%.

Return on Equity (ROE)	-58.07%
Return on Assets (ROA)	-30.08%
Return on Invested Capital (ROIC)	-33.14%
Return on Capital Employed (ROCE)	-57.28%
Weighted Average Cost of Capital (WACC)	9.70%
Revenue Per Employee	n/a
Profits Per Employee	-$1.28M
Employee Count	883
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +204.47% in the last 52 weeks. The beta is 1.01, so RVMD's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+204.47%
50-Day Moving Average	98.65
200-Day Moving Average	67.32
Relative Strength Index (RSI)	45.58
Average Volume (20 Days)	1,915,756

Short Selling Information

The latest short interest is 14.46 million, so 7.30% of the outstanding shares have been sold short.

Short Interest	14.46M
Short Previous Month	14.11M
Short % of Shares Out	7.30%
Short % of Float	8.09%
Short Ratio (days to cover)	6.36

Income Statement

Revenue	n/a
Gross Profit	-987.33M
Operating Income	-1.18B
Pretax Income	-1.13B
Net Income	-1.13B
EBITDA	-1.17B
EBIT	-1.18B
Earnings Per Share (EPS)	-$5.95

Balance Sheet

The company has $2.03 billion in cash and $427.15 million in debt, with a net cash position of $1.60 billion or $8.07 per share.

Cash & Cash Equivalents	2.03B
Total Debt	427.15M
Net Cash	1.60B
Net Cash Per Share	$8.07
Equity (Book Value)	1.63B
Book Value Per Share	8.28
Working Capital	1.78B

Cash Flow

In the last 12 months, operating cash flow was -$897.74 million and capital expenditures -$15.99 million, giving a free cash flow of -$913.73 million.

Operating Cash Flow	-897.74M
Capital Expenditures	-15.99M
Depreciation & Amortization	7.75M
Net Borrowing	n/a
Free Cash Flow	-913.73M
FCF Per Share	-$4.61

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.35%
Shareholder Yield	-13.35%
Earnings Yield	-5.99%
FCF Yield	-4.84%

Analyst Forecast

The average price target for RVMD is $120.47, which is 26.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$120.47
Price Target Difference	26.33%
Analyst Consensus	Strong Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1